Company news
Diagnos Inc. (TSXV:ADK) news
Diagnos Inc. news releases on 6ix. Latest, Oct 6, 2026: DIAGNOS Provides an Update on Stock Warrants
Press releases & updates
DIAGNOS Provides an Update on Stock Warrants
October 6, 2026
DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System
September 28, 2026
DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026
September 14, 2026
DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
August 13, 2026
DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
July 27, 2026
DIAGNOS to Extend the Exercise Period of Stock Warrants
July 7, 2026
DIAGNOS Announces Shares for Debt Settlement
June 18, 2026
DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
June 16, 2026
DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
June 12, 2026
Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
June 5, 2026
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
June 3, 2026
DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
April 8, 2026
DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
April 1, 2026
DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants
March 5, 2026
DIAGNOS : Q3 2026 MD&A – Download as a PDF
February 25, 2026
DIAGNOS : Q3 2026 Financial Statements – Download as a PDF
February 25, 2026
DIAGNOS : Rapport de gestion T3-2026 – Télécharger le PDF
February 25, 2026
DIAGNOS : États financiers T3-2026 – Télécharger le PDF
February 25, 2026
DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
February 24, 2026
DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
February 4, 2026
DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
February 4, 2026
DIAGNOS Announces the Engagement of IBN
January 15, 2026
DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
January 13, 2026
DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare
December 16, 2025
Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
December 9, 2025
Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
November 25, 2025
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
November 13, 2025
DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
November 10, 2025
DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
October 30, 2025
DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board
October 27, 2025
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
October 22, 2025
DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit
October 15, 2025
Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA
October 8, 2025
DIAGNOS Announces Voting Results of Meeting of Shareholders
September 25, 2025
DIAGNOS Announces Closing of Private Placement
September 5, 2025
DIAGNOS Announces Private Placement
September 3, 2025
DIAGNOS to Extend Stock Warrants Exercise Period
August 15, 2025
DIAGNOS Announces Extension of Stock Warrants Exercise Period
August 13, 2025
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
July 16, 2025
DIAGNOS Welcomes Veteran Optometrist Dr. Barry A. Ginsberg to its Scientific Advisory Board for the United States
June 25, 2025
DIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States
June 10, 2025
DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
June 4, 2025
DIAGNOS Announces the Engagement of Allele Capital Partners
May 23, 2025
DIAGNOS Announces Amendment to Convertible Debentures
May 20, 2025
DIAGNOS announces major advances in Cybersecurity certification by the Cyber Defense Operations Center (COCD) for its CARA System application
April 16, 2025
DIAGNOS Provides Additional Information on Amendment to Convertible Debentures
April 14, 2025
DIAGNOS Provides Update on its Health Canada Medical Device Licence Application
April 9, 2025
DIAGNOS Opens First US Office in Florida
March 31, 2025
DIAGNOS is filing for the Saudi FDA Authorization of Its CARA SYSTEM, an AI Assisted Medical Device
March 12, 2025
DIAGNOS to File for FDA Pre-Market Authorization of Its AI-Powered CARA SYSTEM and Engages Ora as Regulatory Specialist
February 25, 2025